NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance, which enables disease to progress unabated by adaptive immunity. However, the drivers of this tolerogenic program are incompletely defined. In this study, we found that NLRP3 promotes expansion of immune-suppressive macrophages in PDA. NLRP3 signaling in macrophages drives the differentiation of CD4+ T cells into tumor-promoting T helper type 2 cell (Th2 cell), Th17 cell, and regulatory T cell populations while suppressing Th1 cell polarization and cytotoxic CD8+ T cell activation. The suppressive effects of NLRP3 signaling were IL-10 dependent. Pharmacological inhibition or deletion of NLRP3, ASC (apoptosis-associated speck-like protein containing a CARD complex), or caspase-1 protected against PDA and was associated with immunogenic reprogramming of innate and adaptive immunity within the TME. Similarly, transfer of PDA-entrained macrophages or T cells from NLRP3−/− hosts was protective. These data suggest that targeting NLRP3 holds the promise for the immunotherapy of PDA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In those cases, IL-1β is the key player, acting as pro-inflammatory, tumor-promoting trigger [126,127,128,129,130].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
The Epidemiology of Pancreatitis and Pancreatic Cancer
Yadav, D., & Lowenfels, A. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.068 · Cited by 1,974 · cited 1×
“1711 IntroductIon Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate approaches the incidence rate (Yadav and Lowenfels, 2013).”
BackgroundPancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,757
Cited by
Items 101–200 of 259
Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
Papafragkos, I., Grigoriou, M., Boon, L., Kloetgen, A., Hatzioannou, A., & Verginis, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889075 · Cited by 34
Zhang, L., Hao, M., Yao, L., Cheng, X., Wen, Q., Zhang, Z., Yu, J., Wang, J., Xing, D., Zheng, T., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145863 · Cited by 33
Shao, Y., Han, S., Hou, Z., Chen, Y., & Zhao, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36839 · Cited by 32
Arrè, V., Scialpi, R., Centonze, M., Giannelli, G., Scavo, M. P., & Negro, R. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00983-7 · Cited by 32
Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis
Balahura, L.-R., Șelaru, A., Dinescu, S., & Costache, M. (2020) · Journal of Immunology Research · doi:10.1155/2020/2549763 · Cited by 32
Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
Barry-Hundeyin, M., Kurz, E., Mishra, A., Rossi, J. A. K., Liudahl, S. M., Leis, K. R., Mehrotra, H., Kim, M., Torres, L. E., Ogunsakin, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0161 · Cited by 31
Self-citationKoizumi, M., Watanabe, T., Masumoto, J., Sunago, K., Imamura, Y., Kanemitsu, K., Kumagi, T., & Hiasa, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-01465-2 · Cited by 31
Inflammasomes in cancer: Effect of epigenetic and autophagic modulations
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Bhol, C. S., Praharaj, P. P., Panigrahi, D. P., Patra, S., Singh, A., Patil, S., Dhiman, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.013 · Cited by 31
Inflammasome activity regulation by PUFA metabolites
Atalay, S., Gęgotek, A., & Skrzydlewska, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1452749 · Cited by 30
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wang, W., Marinis, J. M., Beal, A. M., Savadkar, S., Wu, Y., Khan, M., Taunk, P. S., Wu, N., Su, W., Wu, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.020 · Cited by 30
Self-citationProgress in the study of molecular mechanisms of cell pyroptosis in tumor therapy
Wang, D., & Wan, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110143 · Cited by 29
Vinaik, R., Stanojcic, M., & Jeschke, M. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-33486-9 · Cited by 29
Targeting inflammasomes as an immunotherapeutic strategy for cancer
Huang, L., Chen, X., Liu, R., Nan, D., Bao, W., Yang, L., Dai, X., Tang, J., Zhang, H., & Lu, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06665-2 · Cited by 28
Characterization of genetic subclonal evolution in pancreatic cancer mouse models
Niknafs, N., Zhong, Y., Moral, J. A., Zhang, L., Shao, M. X., Lo, A., Makohon-Moore, A. P., Iacobuzio–Donahue, C. A., & Karchin, R. (2019) · Nature Communications · doi:10.1038/s41467-019-13100-w · Cited by 28
Wang, W., Xu, S.-W., Teng, Y., Zhu, M., Guo, Q., Wang, Y., Mao, X., Li, S.-W., & Luo, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.779123 · Cited by 28
Self-citationZhao, T., Xiao, D., Jin, F., Sun, X., Yu, J., Wang, H., Liu, J., Cai, W., Huang, C., Wang, X., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01927-y · Cited by 28
Kim, S. H., Saeidi, S., Zhong, X., Gwak, S.-Y., Muna, I. A., Park, S., Kim, S. H., Na, H., Joe, Y., Chung, H., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.08.006 · Cited by 28
Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity
Guo, Y., Tsai, H., Zhang, L., & Zhu, H. (2022) · Cancers · doi:10.3390/cancers14061452 · Cited by 27
Zhu, X., Xu, Y., Wang, J., Xue, Z., Qiu, T., & Chen, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1165602 · Cited by 27
TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer
Wu, J., Wang, Y., & Jiang, Z. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00371-6 · Cited by 27
Li, G. Q., Gao, S. X., Wang, F. H., Kang, L., Tang, Z. Y., & Xiao, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115019 · Cited by 26
Focus on Pancreatic Cancer Microenvironment
Pratticò, F., & Garajová, I. (2024) · Current Oncology · doi:10.3390/curroncol31080316 · Cited by 26
Boone, B. A., Murthy, P., Miller-Ocuin, J. L., Liang, X., Russell, K. L., Loughran, P., Gawaz, M., Lotze, M. T., Zeh, H. J., & Vogel, S. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03692-0 · Cited by 26
Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Looi, C.-K., Hii, L., Chung, F. F., Mai, C., Lim, W., & Leong, C. (2021) · Cancers · doi:10.3390/cancers13081786 · Cited by 26
Serum uric acid and its metabolism-a vital factor in the inflammatory transformation of cancer
Li, Z., Su, Y., Su, H., Pan, J., Li, S., Lu, L., Ji, G., & Xu, H. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.031 · Cited by 25
New prospects of cancer therapy based on pyroptosis and pyroptosis inducers
Chen, Q., Sun, Y., Wang, S., & Xu, J. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01906-5 · Cited by 25
Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
Morrow, Z. T., Powers, Z. M., & Sauer, J. (2019) · Current Clinical Microbiology Reports · doi:10.1007/s40588-019-00133-4 · Cited by 25
Lang, C., Roy, S., Wang, Y., Graves, D. K., Xu, Y., Serezani, C. H., Korrer, M. J., & Kim, Y. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993771 · Cited by 24
Zhang, D., Cui, F., Zheng, K., Li, W., Liu, Y., Wu, C., Peng, L., Yang, Z., Chen, Q.-Q., Xia, C., et al. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003130 · Cited by 24
Duan, S., Wang, N., Huang, L., Shao, H., Zhang, P., Wang, W. T., Wu, Y., Wang, J., Liu, H., Zhang, Q., et al. (2019) · Environmental Toxicology · doi:10.1002/tox.22725 · Cited by 24
Self-citationKim, S. M., Jeon, Y., Jang, J. Y., & Lee, H. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01554-3 · Cited by 23
Mechanisms and effects of NLRP3 in digestive cancers
Si, Y., Liu, L., & Fan, Z. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01783-6 · Cited by 23
Deipenbrock, A., Wilmes, B. E., Sommermann, T. G., Abdo, N., Moustakas, K., Raasch, M., Rennert, K., & Teusch, N. E. (2025) · Lab on a Chip · doi:10.1039/d4lc01016g · Cited by 22
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis
Theivanthiran, B., Haykal, T., Cao, L., Holtzhausen, A., Plebanek, M. P., DeVito, N. C., & Hanks, B. A. (2021) · Cancers · doi:10.3390/cancers13194753 · Cited by 23
Challagundla, N., Saha, B., & Agrawal-Rajput, R. (2022) · Immunologic Research · doi:10.1007/s12026-022-09286-9 · Cited by 22
A small molecule directly targets NLRP3 to promote inflammasome activation and antitumor immunity
Liu, X., He, H., Qi, M., Jiang, Z., Lin, B., Wang, X., Wang, D., Ma, M., Jiang, W., & Zhou, R. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07578-0 · Cited by 21
Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy
Jiao, Z., & Zhang, J. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad072 · Cited by 21
Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy
Li, L., Chen, L., & Sun, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122951 · Cited by 21
O’Donovan, D. H., Mao, Y., & Mele, D. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190620103105 · Cited by 21
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Hreich, S. J. D., Hofman, P. M., & Vouret‐Craviari, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119235 · Cited by 21
Amo‐Aparicio, J., Dominguez, A. T. A., Atif, S. M., Dinarello, A., Azam, T., Alula, K. M., Piper, M., Lieu, C. H., Lentz, R. W., Leal, A. D., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0065 · Cited by 20
Liang, T., Gu, L., Kang, X., Li, J., Song, Y., Wang, Y., & Ma, W. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01602-0 · Cited by 20
Lin, H., Tam, P. K. H., & Deng, C. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.115932 · Cited by 20
Liang, Q., Wu, J., Zhao, X. S., Shen, S., Zhu, C., Liu, T., Cui, X., Chen, L., Wei, C., Cheng, P., et al. (2021) · Theranostics · doi:10.7150/thno.63202 · Cited by 20
Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers
Liou, G. (2017) · Journal of Immunology Research · doi:10.1155/2017/7979637 · Cited by 20
The effects of NOD-like receptors on adaptive immune responses
Tsankov, B. K., Luchak, A., Carr, C., & Philpott, D. J. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100637 · Cited by 19
Guo, L., Yang, Y., Sheng, Y., Wang, J., Li, W., Zhou, X., Ruan, S., & Han, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.752118 · Cited by 19
Ren, J., Li, X., Zhu, S., Yin, B., Guo, Z., Cui, Q., Song, J., Pei, H., & Ma, Y. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02470 · Cited by 19
Regulation of cancer by inflammasomes: from inflammation to tumorigenesis
Malvankar, S., Jaiswal, P., Bhat, P. P., & Mehto, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1611719 · Cited by 19
Liu, W., Zhang, F., Quan, B., Yao, F., Chen, R., Ren, Z., & Yin, X. H. (2023) · MedComm · doi:10.1002/mco2.447 · Cited by 18
Diskin, B. E., Adam, S., Soto, G. S., Liria, M., Aykut, B., Sundberg, B., Li, E. H., Leinwand, J., Chen, R., Kim, M., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02425-4 · Cited by 18
Self-citationFraile‐Μartinez, O., Montero, C. G., Pekarek, L., Saz, J. V., Álvarez-Mon, M. Á., Barrena-Blázquez, S., García‐Honduvilla, N., Buján, J., Asúnsolo, Á., Coca, S., et al. (2024) · PubMed · doi:10.14670/hh-18-617 · Cited by 17
Yin, B., Ren, J., Cui, Q., Liu, X., Wang, Z., Pei, H., Zuo, J., Zhang, Y., Wen, R., Sun, X., et al. (2023) · Food & Function · doi:10.1039/d3fo03641c · Cited by 17
Coudereau, R., Bodinier, M., Lukaszewicz, A., Py, B. F., Argaud, L., Cour, M., Bidar, F., Cerrato, E., Garnier, L., Gossez, M., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad161 · Cited by 17
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer
Dawson, R., & Jenkins, B. J. (2024) · Immune Network · doi:10.4110/in.2024.24.e38 · Cited by 16
He, S., Gu, X., Yang, J., Xu, F., Hu, J., Wang, W., Huang, Y., Lou, B., Ding, T., Zhou, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902016 · Cited by 16
Self-citationNLRP3 inflammasome: From drug target to drug discovery
Yin, L., Zhang, H., Shang, Y., Wu, S., & Jin, T. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104375 · Cited by 15
Interleukin-1 signaling in solid organ malignancies
Dosch, A. R., Singh, S. P., Nagathihalli, N. S., Datta, J., & Merchant, N. B. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188670 · Cited by 15
Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
Bastos, A. R., Pereira‐Marques, J., Ferreira, R. M., & Figueiredo, C. (2023) · Cancers · doi:10.3390/cancers15092629 · Cited by 15
Du, Y., Dong, S., Jiang, W., Li, M., Li, W., Li, X., & Zhou, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612787 · Cited by 14
Cx43 phosphorylation sites regulate pancreatic cancer metastasis
Solan, J. L., Hingorani, S. R., & Lampe, P. D. (2021) · Oncogene · doi:10.1038/s41388-021-01668-x · Cited by 14
Li, L., Wu, L., Yin, X., Li, C., & Hua, Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1803544 · Cited by 14
Pratt, H. G., Ma, L., Dziadowicz, S. A., Ott, S., Whalley, T., Szomolay, B., Eubank, T. D., Hu, G., & Boone, B. A. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1595 · Cited by 13
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome
Far, N. P., Varnousafaderani, M. H., Faghihkhorasani, F., Etemad, S., Abdulwahid, A. R. R., Bakhtiarinia, N., Mousaei, A., Dortaj, E., Karimi, S., Ebrahimi, N., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17352 · Cited by 13
Zhang, G., Yao, Y., Zhang, Z., Xiao, J., Yu, H., Zhao, J., Yao, C., Wang, Y., & Luo, H. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156194 · Cited by 13
Owida, H. A., Abed, A. Y., Altalbawy, F. M. A., Malathi, H., Abbot, V., Jakhonkulovna, S. M., Mohammad, S. I. S., Vasudevan, A., Khalaf, R. M., & Zwamel, A. H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04030-0 · Cited by 13
Deshpande, N., Bianchi, A., Amirian, H., Silva, I. D. C., Rafie, C. I., Surnar, B., Rajkumar, K., Ogobuiro, I. C., Patel, M., Mehra, S., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04096-y · Cited by 13
Luo, L., Wei, Q., Xu, C., Dong, M., & Zhao, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933703 · Cited by 13
A novel pyroptosis gene expression-based risk score for survival in gastric cancer
Hu, J., Song, Y., Cai, X., Halike, H., Qiao, K., Lu, J., Yin, C., & Gao, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1120216 · Cited by 13
Lu, Q., Lao, X., Gan, J., Du, P., Zhou, Y., Nong, W., & Yang, Z. (2023) · Infectious Agents and Cancer · doi:10.1186/s13027-023-00529-4 · Cited by 13
Zhang, Y., & Zhou, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116667 · Cited by 13
Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis
Khilwani, R., & Singh, S. (2023) · Biomedicines · doi:10.3390/biomedicines11102706 · Cited by 12
Sivam, H. G. P., Chin, B. Y., Gan, S. Y., Ng, J. H., Gwenhure, A., & Chan, E. W. L. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2284857 · Cited by 12
NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells
Nagai-Singer, M. A., Morrison, H. A., Woolls, M. K., Leedy, K., Imran, K. M., Tupik, J. D., & Allen, I. C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155831 · Cited by 11
Stergiou, I. Ε., Tsironis, C., Papadakos, S. P., Tsitsilonis, O., Dimopoulos, M. A., & Theocharis, S. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042369 · Cited by 11
Hashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 11
NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development
Filippo, M. D., Hennig, P., Karakaya, T., Slaufova, M., & Beer, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012308 · Cited by 10
Macrophage activation determines muscle wasting in pancreatic cancer
Chang, C., Huang, P.-H., Chen, S.-Y., Su, P.-C., Ding, L.-Y., Hou, Y., Hung, M., Chen, K.-L., Wu, Y., Wu, S., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03434-9 · Cited by 9
Pathophysiological roles of monocytes and macrophages in cancer
Ji, L., Li, J., Hsu, T.-W., & Li, M. O. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01296-0 · Cited by 9
Persistent expression of NLRP3 in spinal microglia promotes development of lumbar disc degeneration
Wang, P., & Zhang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1064303 · Cited by 9
Halle-Smith, J. M., Pearce, H., Nicol, S. M., Hall, L. A., Powell-Brett, S. F., Beggs, A. D., Iqbal, T. H., Moss, P. A. H., & Roberts, K. J. (2024) · Cancers · doi:10.3390/cancers16050996 · Cited by 9
Zuo, J., Yi, C., Chen, Z., Zhou, B., Yang, T., & Lin, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-22864-z · Cited by 9
Zhou, Q., Chen, D., Zhang, J., Xiang, J.-F., Zhang, T., Wang, H., & Zhang, Y. (2022) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000109 · Cited by 9
Bilgin, E., Dızdar, Ö., Güven, D. C., Ceylan, S., Aybı, Ö., Fırlatan, B., Kardaş, R. C., Yıldırım, T., Hayran, M., Kalyoncu, U., et al. (2019) · Rheumatology International · doi:10.1007/s00296-019-04311-x · Cited by 8
Sun, J., Tang, Q., Zhang, J., Chen, G., Peng, J., & Chen, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.717038 · Cited by 8
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
Nolfi, M. D. V., Vecchiotti, D., Flati, I., Verzella, D., Padova, M. D., Alesse, E., Capece, D., & Zazzeroni, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933922 · Cited by 8
The role of NLRP3 inflammasome in digestive system malignancy
Sun, C.-C., Li, L., Tao, H., Jiang, Z.-C., Wang, L., & Wang, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1051612 · Cited by 8
Role of gut microbiota in tumorigenesis and antitumoral therapies: an updated review
Singhal, S., Bhadana, R., Jain, B. P., Gautam, A., Pandey, S., & Rani, V. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2166268 · Cited by 7
Determinants for Antitumor and Protumor Effects of Programmed Cell Death
Workenhe, S. T., Inkol, J. M., Westerveld, M. J., Verburg, S. G., Worfolk, S. M., Walsh, S. R., & Kallio, K. L. F. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0321 · Cited by 7
Boccia, T., Pan, W., Fattori, V., Cervantes‐Díaz, R., Rogers, M. S., Zanoni, I., & Cuenca, A. G. (2025) · iScience · doi:10.1016/j.isci.2025.112653 · Cited by 6
Zhou, Y., Wang, B., Wang, Q., Wang, F., Mou, X., Gong, L., & Li, W. (2025) · mBio · doi:10.1128/mbio.02392-25 · Cited by 6
Inflammation and de-differentiation in pancreatic carcinogenesis
Seimiya, T., Otsuka, M., Iwata, T., Tanaka, E., Suzuki, T., Sekiba, K., Yamagami, M., Ishibashi, R., & Koike, K. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i15.882 · Cited by 6
The entanglement of DNA damage and pattern recognition receptor signaling
Ha, C. T., Tageldein, M. M., & Harding, S. M. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103595 · Cited by 6
Bai, R.-L., Wang, N.-Y., Zhao, L., Zhang, Y., & Cui, J. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.08.012 · Cited by 6
Zhang, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104891 · Cited by 5
Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells
Tezcan, G., Al-Saadi, A., Hamza, S., Garanina, E. E., Martynova, E. V., Ziganshina, G. R., Farukshina, E. R., Rizvanov, A. A., & Khaiboullina, S. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169484 · Cited by 5
Gut Microbiota and Cancer Correlates
Malaviya, A., Paari, K. A., Malviya, S., Kondapalli, V. K., Ghosh, A., & Samuel, R. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_1 · Cited by 5
Dhanjal, C. R., Lingamsetty, R., Pareddy, A., Kim, S., & Raval, R. (2022) · Marine Drugs · doi:10.3390/md20070452 · Cited by 5
Sun, Y., Li, Y., Zhang, A., Hu, T., & Li, M. (2025) · Discover Oncology · doi:10.1007/s12672-025-02733-7 · Cited by 4
Matsumoto, R., Tanoue, K., Nakayama, C., Okawa, M., Hozaka, Y., Idichi, T., Mataki, Y., & Ohtsuka, T. (2025) · Cancers · doi:10.3390/cancers17183090 · Cited by 4
Metadata
- Authors
- Daley, D., Mani, V. R., Mohan, N., Akkad, N., Pandian, G. S. D. B., Savadkar, S., Lee, K. B., Torres-Hernandez, A., Aykut, B., Diskin, B., Wang, W., Farooq, M. S., Mahmud, A. I., Werba, G., Morales, E. J., Lall, S., Wadowski, B. J., Rubin, A. G., Berman, M. E., Narayanan, R., Hundeyin, M., & Miller, G.
- Affiliations
- New York University (US)
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, NY 10016 1
- Corresponding author
- Miller, George
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-04-25
- Volume
- 214
- Issue
- 6
- Pages
- 1711-1724
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5461004
- OpenAlex
- W2608757343
- Cited by
- 244
- References
- 49
- Citations by year
- 2026: 11 · 2025: 28 · 2024: 24 · 2023: 44 · 2022: 42 · 2021: 29 · 2020: 22 · 2019: 28 · 2018: 12 · 2017: 4
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA168611, CA155649, CA206105)
- Department of Defense
- Lustgarten Foundation
- American Association for Cancer Research
- Pancreatic Cancer Action Network
- Hirshberg Foundation for Pancreatic Cancer Research
- Irene and Bernard Schwartz Fellowship in Gastrointestinal Oncology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- NLRP3 inflammasome, pancreatic ductal adenocarcinoma, tumor microenvironment, tumor-associated macrophages, IL-10, Th17 cells, regulatory T cells, Th2 cells, CD8+ T cell activation, ASC, caspase-1, immunotherapy, macrophage reprogramming
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Mice, Inbred C57BL, Pancreatic Neoplasms, T-Lymphocytes, Signal Transduction, Gene Deletion, Caspase 1, Carcinoma, Pancreatic Ductal, Cell Proliferation, Apoptosis Regulatory Proteins, CARD Signaling Adaptor Proteins, Nod2 Signaling Adaptor Protein, Adaptive Immunity, Pancreatic Stellate Cells, Tumor Microenvironment, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.